Colorectal Neoplasms: all 5,738 studies
Page 38 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.
- Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer ScreeningCompletedNCT03414125Not applicable
- Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal CancerStatus unknownNCT03412994Phase 2
- Multiple Screening Methods for the Detection of Chinese Colorectal Advanced Adenomatous Polyps and CancerStatus unknownNCT03411707
- Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRCStatus unknownNCT03405272Phase 2
- Apatinib in the Treatment of Metastatic Colorectal CancerStatus unknownNCT03403452Phase 2
- The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab TreatmentStatus unknownNCT03401957
- MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal CancerStatus unknownNCT03400657
- HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal CancerTerminatedNCT03398512Not applicable
- Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal CancerStatus unknownNCT03397199Phase 2
- Tailored Written Lifestyle Feedback in Colorectal Cancer ScreeningCompletedNCT03396029Not applicable
- Uncovering the Barriers of Colorectal Cancer Screening Amongst Siblings of Colorectal Cancer Patients.CompletedNCT03395938Not applicable
- Metastatic Colorectal Cancer Patients With Long-term Response to RegorafenibCompletedNCT03386825
- Gut Mucosal Microbiota is Associated With Colorectal Cancer RelapseStatus unknownNCT03385213
- The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal PatientsStatus unknownNCT03385148Early Phase 1
- Colorectal Cancer Screening French Organizations for the Follow-up After ColonoscopyStatus unknownNCT03383367Not applicable
- Gut Microbiota Prediction of Metachronous Colorectal NeoplasmsStatus unknownNCT03383159
- REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal AnastomosisStatus unknownNCT03380858
- Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal CancerWithdrawnNCT03380689Phase 1
- Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal CancerStatus unknownNCT03377842Phase 2
- VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerCompletedNCT03373188Phase 1
- Vitamin D, Genes and Colorectal CancerCompletedNCT03370432
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal CancerCompletedNCT03367611Not applicable
- Systemic Screening for Hereditary Colorectal Cancer in ChinaStatus unknownNCT03365986
- mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal CancerCompletedNCT03365765Phase 3
- Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer TherapyActive, not recruitingNCT03364621
- Dietary Patterns, Metabolomics and Colorectal Cancer RiskCompletedNCT03364582
- PETACC-8 miR-31-3p and miR-31-5p Ancillary StudyCompletedNCT03362684Phase 3
- High-Intensity Interval vs. Moderate Continuous Training in Surgical Prehabilitation.CompletedNCT03361150Not applicable
- Mix Vaccine for Metastatic Colorectal CancerCompletedNCT03357276Phase 1/2
- A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal CancerStatus unknownNCT03356158Phase 1
- Characterization of Brazilian Colorectal Cancer Screening PopulationStatus unknownNCT03355391
- Application of Carbon Nanoparticles in Laparoscopic Colorectal SurgeryStatus unknownNCT03350945Not applicable
- Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical TrialsStatus unknownNCT03350412
- Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT03346980
- Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM)CompletedNCT03346005Not applicable
- A Study of Apatinib in Combination With Raltitrexed Treatment in Patients With Advanced Colorectal CancerStatus unknownNCT03344614Phase 2
- Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal CancerWithdrawnNCT03340558Phase 2
- Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer PatientsCompletedNCT03337347Not applicable
- Enhancing Fitness With Preoperative Exercise in Colorectal Cancer SurgeryStatus unknownNCT03336229Not applicable
- CRC Post-surgical Assessment and Recurrence MonitoringStatus unknownNCT03334890
- Randomized Trial of eOncoNoteCompletedNCT03333785Not applicable
- High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28Status unknownNCT03329183Phase 2
- Aspirin in Colorectal Cancer Liver MetastasesCompletedNCT03326791Phase 2/3
- Mometasone vs Budesonide in CRS With PolyposisTerminatedNCT03323866Phase 3
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCompletedNCT03317119Phase 1
- Intraoperative Testing of Colorectal Anastomosis - Air or Water (Methylene Blue)?Status unknownNCT03316677Not applicable
- ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal CancerStatus unknownNCT03312374
- Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal CancerTerminatedNCT03311750Phase 2
- Tailored Messaging for CRC ScreeningCompletedNCT03310892Not applicable
- Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal CancerWithdrawnNCT03307603Phase 1/2
- A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).CompletedNCT03306394Phase 3
- Regorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard TherapyCompletedNCT03305913Phase 1
- Child-Physician Recommendation on Parental Adherence to Colorectal Cancer ScreeningCompletedNCT03304860Not applicable
- 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus PanitumumabTerminatedNCT03300609Phase 3
- Study of Gut Microbiome and Colorectal TumorsCompletedNCT03297996
- Circulating Tumor Cells in mCRC for Liver ResectionStatus unknownNCT03295591
- Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid TumorsCompletedNCT03295084Phase 1
- Risk-Reducing Surgeries for Hereditary Ovarian CancerStatus unknownNCT03294343Not applicable
- Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial CancerStatus unknownNCT03291106
- Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal CancerCompletedNCT03290937Phase 1
- Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel ExpressionStatus unknownNCT03289988
- A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsCompletedNCT03289962Phase 1
- Educational Intervention - Improving Knowledge and Screening Rates for Colorectal CancerCompletedNCT03287453Not applicable
- Pattern of Use of Bevacizumab or Cetuximab + FOLFIRI Regimen as First-line Treatment in Metastatic Colorectal CancerStatus unknownNCT03286738
- Nurse Navigation Versus Current Care Coordination During Colorectal Cancer TrajectoriesCompletedNCT03281447Not applicable
- NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal CancerStatus unknownNCT03280407Phase 2
- Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based RegimenCompletedNCT03279289Phase 2
- Increasing Colorectal and Breast Cancer Screening in WomenCompletedNCT03279198Not applicable
- Effect of a Resilience Model-Based Program for Patients With Newly Diagnosed Colorectal CancerCompletedNCT03277235Not applicable
- Promoting Cancer Screening Among Medicaid Recipients in MinnesotaCompletedNCT03275987Not applicable
- Glutamine PET Imaging Colorectal CancerTerminatedNCT03275974Phase 1
- Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard ChemotherapiesCompletedNCT03274882Phase 2
- The Effect of Ketamine on Immune Function and Prognosis in Patients Undergoing Colorectal Cancer ResectionStatus unknownNCT03273231Not applicable
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic DiagnosticsWithdrawnNCT03272659Phase 2
- Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Status unknownNCT03271255Phase 2
- Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
- Comparative Effectiveness of FITs With ColonoscopyCompletedNCT03264898
- Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal CancerWithdrawnNCT03264274Phase 2
- Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810Status unknownNCT03260179Phase 1
- RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)Status unknownNCT03259009
- Effectiveness of a Psychosocial Intervention for Colorectal CancerCompletedNCT03258450Not applicable
- A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal CancerCompletedNCT03258398Phase 2
- Sleep and Survival in Colorectal CancerStatus unknownNCT03254836
- The Effect of a Colorectal Cancer Screening Decision Aid Tailored to Lower Educational Attainment CitizensCompletedNCT03253822Not applicable
- A Study of SC-007 in Subjects With Advanced CancerTerminatedNCT03253185Phase 1
- Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal CancerCompletedNCT03251612Phase 2
- Diet, Genes and Colorectal Cancer - With Focus on Toll-like Receptor PolymorphismsCompletedNCT03250637
- Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing ColonoscopyTerminatedNCT03249727Not applicable
- PIPAC for Peritoneal Metastases of Colorectal CancerCompletedNCT03246321Phase 2
- Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use DisorderCompletedNCT03244787Not applicable
- Comparison of the Effectiveness of Bowel Preparations Before ColonoscopyStatus unknownNCT03242369Not applicable
- Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerCompletedNCT03233555Not applicable
- Walk on: A Community-based Approach to Increase Physical Activity Among Men Treated for Colorectal CancerWithdrawnNCT03232814Not applicable
- The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and VomitingCompletedNCT03232541Not applicable
- First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTSCompletedNCT03231722Phase 3
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
- Apatinib for Resectable Colorectal CancerWithdrawnNCT03228043Not applicable
- Rechallenge With Panitumumab Driven by RAS Dynamic of ResistanceCompletedNCT03227926Phase 2